Objectives: This study explored the specific medication-related burdens experienced by older adults with chronic disease and the contributing factors. Methods: An exploratory mixed-method study was conducted at a teaching hospital in Surakarta City, Central Java, Indonesia. Combining the Indonesian version of the Living with Medicine Questionnaire (LMQ) and semi-structured interviews allowed for a comprehensive understanding of the medication-related burden. Differences in LMQ scores related to patient characteristics were analyzed using the t-test, F-test, or other alternatives. Quantitative and qualitative data triangulation was used to derive trustworthy and dependable results. Results: The overall LMQ mean score was 90.4 (n=129), indicating a moderate burden. The average LMQ scores varied significantly based on the number of medications, treatment duration, and the presence of cardiovascular disease (CVD), diabetes mellitus (DM) and stroke. The qualitative study found 3 themes in the chronic medication use of older adults: experiences, challenges, and motivation. Despite their limited understanding of a medication’s name and indication, some patients managed their medications based on the physical look and packaging of the medication. The study also found that patient motivation and familial support could effectively counteract the fatigue and dissatisfaction associated with taking medication. Conclusions Older adults with chronic diseases faced medication-related burdens associated with the presence of CVD, DM, stroke, a treatment duration >5 years, and the use of >10 medications. Effective communication with healthcare professionals is required to understand patients’ needs and concerns, thereby helping manage the challenges of medication-related burdens.

Objectives: This study explored the specific medication-related burdens experienced by older adults with chronic disease and the contributing factors. Methods: An exploratory mixed-method study was conducted at a teaching hospital in Surakarta City, Central Java, Indonesia. Combining the Indonesian version of the Living with Medicine Questionnaire (LMQ) and semi-structured interviews allowed for a comprehensive understanding of the medication-related burden. Differences in LMQ scores related to patient characteristics were analyzed using the t-test, F-test, or other alternatives. Quantitative and qualitative data triangulation was used to derive trustworthy and dependable results. Results: The overall LMQ mean score was 90.4 (n=129), indicating a moderate burden. The average LMQ scores varied significantly based on the number of medications, treatment duration, and the presence of cardiovascular disease (CVD), diabetes mellitus (DM) and stroke. The qualitative study found 3 themes in the chronic medication use of older adults: experiences, challenges, and motivation. Despite their limited understanding of a medication’s name and indication, some patients managed their medications based on the physical look and packaging of the medication. The study also found that patient motivation and familial support could effectively counteract the fatigue and dissatisfaction associated with taking medication. Conclusions Older adults with chronic diseases faced medication-related burdens associated with the presence of CVD, DM, stroke, a treatment duration >5 years, and the use of >10 medications. Effective communication with healthcare professionals is required to understand patients’ needs and concerns, thereby helping manage the challenges of medication-related burdens.

Objectives: This study explored the specific medication-related burdens experienced by older adults with chronic disease and the contributing factors. Methods: An exploratory mixed-method study was conducted at a teaching hospital in Surakarta City, Central Java, Indonesia. Combining the Indonesian version of the Living with Medicine Questionnaire (LMQ) and semi-structured interviews allowed for a comprehensive understanding of the medication-related burden. Differences in LMQ scores related to patient characteristics were analyzed using the t-test, F-test, or other alternatives. Quantitative and qualitative data triangulation was used to derive trustworthy and dependable results. Results: The overall LMQ mean score was 90.4 (n=129), indicating a moderate burden. The average LMQ scores varied significantly based on the number of medications, treatment duration, and the presence of cardiovascular disease (CVD), diabetes mellitus (DM) and stroke. The qualitative study found 3 themes in the chronic medication use of older adults: experiences, challenges, and motivation. Despite their limited understanding of a medication’s name and indication, some patients managed their medications based on the physical look and packaging of the medication. The study also found that patient motivation and familial support could effectively counteract the fatigue and dissatisfaction associated with taking medication. Conclusions Older adults with chronic diseases faced medication-related burdens associated with the presence of CVD, DM, stroke, a treatment duration >5 years, and the use of >10 medications. Effective communication with healthcare professionals is required to understand patients’ needs and concerns, thereby helping manage the challenges of medication-related burdens.

Introduction: The purpose of this research was to analyze the relationships between pharmacists knowledge, work environment, and self-efficacy to their compliance level with the COVID-19 health protocols. Methods: This cross-sectional study was designed with descriptive correlational data collection using a questionnaire. Simple random sampling was used to choose the participants who are pharmacists from the Special Region of Yogyakarta’s Province. The demographic characteristics of the respondent were presented descriptively. The demographic characteristics of the respondent were presented descriptively. A statistical test was used to assess the correlation between compliance level vs each of the three factors from the Social Cognitive Theory. Results: A total of 262 pharmacists were selected with data collection using a questionnaire. Most of them were in a medium level of compliance (65.6%), while only 19.1% in a high level, and the 15,3% in a low level. Correlation values of 0.463 and 0.409 between variables measuring the organization’s environment and self-effciacy were found to be statistically significant at the p value <0.05. Meanwhile, there was no statistically significant relationship between knowledge and compliance (p>0.05) with correlation value was 0.054. There is good compliance to the COVID-19 health protocols among community pharmacists in the Special Region of Yogyakarta. Conclusion: These findings indicate that improving factors from pharmacy organization-environmental and self-efficacy of pharmacists may improve community pharmacists level of compliance to COVID-19 health protocols in pandemic era.